TABLE II.
HSP90 vs. β-Actin |
LEDGF/p75a vs. β-Actin |
P21 vs. β-Actin |
APOBEC3G vs. β-Actin |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Group | Total | No. (%) | Fold change |
P-value | Fold change |
P-value | Fold change |
P-value | Fold change |
P-value |
Gender | 49 | |||||||||
Female | 35 (71.4) | Ref | Ref | Ref | Ref | |||||
Male | 14 (28.6) | 1.05 | 0.68 | 1.02 | 0.69 | −1.14 | 0.70 | 1.73 | 0.23 | |
Ethnicity | 49 | |||||||||
Hispanic | 40 (83.3) | Ref | Ref | Ref | Ref | |||||
Not Hispanic | 9 (18.4) | 1.06 | 0.68 | 1.04 | 0.61 | −1.18 | 0.67 | 1.45 | 0.48 | |
Infection status | 49 | |||||||||
Uninfected | 16 (32.7) | Ref | Ref | Ref | Ref | |||||
Infected | 33 (67.3) | −1.43 | 0.01 | −1.26 | 0.001 | 2.35 | 0.03 | −4.71 | 0.003 |
Note: The fold changes were obtained from the 2−ΔΔCt method in multiplicative effect. Ref, Reference group.
LEDGF/p75 was transformed by the natural log in all models to better meet the residual normality criterion of linear regression.
The bold face highlights the significant p-values.